Hyo-Soo Kim, Kim
Seoul National University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hyo-Soo Kim, Kim as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:23 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT03228238 · ANti-Oxidant in Variant Angina (ANOVA) TrialSeoul National University Hospital · terminated · Variant Angina · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:23 UTC. The ranking covers the 200 most relevant of 253 PubMed records, and a shared surname and initials can bring in a namesake. All 253 on PubMed
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.Lancet Oncol · 2014868 citationsRCR 26.4
- Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis.N Engl J Med · 2020423 citationsRCR 21.7
- 322 citationsRCR 19.6
- 247 citationsRCR 6.0
- 213 citationsRCR 6.1
- 181 citationsRCR 5.8
- Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.Clin Infect Dis · 2017170 citationsRCR 8.5
- Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects.Clin Nutr · 2003169 citationsRCR 4.6
- Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer.J Thorac Oncol · 2015158 citationsRCR 6.2
- Use of non-invasive NIRS during a vascular occlusion test to assess dynamic tissue O(2) saturation response.Intensive Care Med · 2008153 citationsRCR 5.7